IBBR Publications

Found 524 results
Filters: Keyword is Humans  [Clear All Filters]
2011
Wang XXiang, Li Y, Yin Y, Mo M, Wang Q, Gao W, Wang L, Mariuzza RA. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci U S A. 2011 ;108(38):15960-5.
Kim M, Sun Z-YJ, Rand KD, Shi X, Song L, Cheng Y, Fahmy AF, Majumdar S, Ofek GA, Yang Y, et al. Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat Struct Mol Biol. 2011 ;18(11):1235-43.
Pan M, Kelman LM, Kelman Z. The archaeal PCNA proteins. Biochem Soc Trans. 2011 ;39(1):20-4.
Zeng Y, He Y, Yang F, Mooney SM, Getzenberg RH, Orban J, Kulkarni P. The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J Biol Chem. 2011 ;286(16):13985-94.
Boston SR, Deshmukh R, Strome S, U Priyakumar D, Mackerell AD, Shapiro P. Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. BMC Cancer. 2011 ;11:7.
Held W, Mariuzza RA. Cis-trans interactions of cell surface receptors: biological roles and structural basis. Cell Mol Life Sci. 2011 ;68(21):3469-78.
Heo G-Y, Bederman I, Mast N, Liao W-L, Turko IV, Pikuleva IA. Conversion of 7-ketocholesterol to oxysterol metabolites by recombinant CYP27A1 and retinal pigment epithelial cells. J Lipid Res. 2011 ;52(6):1117-27.
Zhu Z, Qin HRebekah, Chen W, Zhao Q, Shen X, Schutte R, Wang Y, Ofek GA, Streaker E, Prabakaran P, et al. Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J Virol. 2011 ;85(21):11401-8.
Vasaitis TS, Bruno RD, Njar VCO. CYP17 inhibitors for prostate cancer therapy. J Steroid Biochem Mol Biol. 2011 ;125(1-2):23-31.
Nelson DC, Garbe J, Collin M. Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol Chem. 2011 ;392(12):1077-88.
Jiang J, Zhang J, Li S. Detecting protein interactions in live cells via complementation of a hydrolysis-deficient β-lactamase. Chem Commun (Camb). 2011 ;47(1):182-4.
Roy V, Adams BL, Bentley WE. Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing. Enzyme Microb Technol. 2011 ;49(2):113-23.
Liu Y, Cheng Y, Wu H-C, Kim E, Ulijn RV, Rubloff GW, Bentley WE, Payne GF. Electroaddressing agarose using Fmoc-phenylalanine as a temporary scaffold. Langmuir. 2011 ;27(12):7380-4.
Busby B, Oashi T, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Mackerell AD, Bloch RJ. Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies. J Mol Biol. 2011 ;408(2):321-34.
Shuvaev VV, Ilies MA, Simone E, Zaitsev S, Kim Y, Cai S, Mahmud A, Dziubla T, Muro S, Discher DE, et al. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano. 2011 ;5(9):6991-9.
Hsu J, Serrano D, Bhowmick T, Kumar K, Shen Y, Kuo YChia, Garnacho C, Muro S. Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release. 2011 ;149(3):323-31.
Guenaga J, Dosenovic P, Ofek GA, Baker D, Schief WR, Kwong PD, Hedestam GBKarlsson, Wyatt RT. Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant. PLoS One. 2011 ;6(1):e16074.
Chen CZ, Kulakova L, Southall N, Marugan JJ, Galkin A, Austin CP, Herzberg O, Zheng W. High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements. Antimicrob Agents Chemother. 2011 ;55(2):667-75.
Charvet C, Liao W-L, Heo G-Y, Laird J, Salomon RG, Turko IV, Pikuleva IA. Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1. J Biol Chem. 2011 ;286(23):20413-22.